1.
J Affect Disord
; 297: 145-147, 2022 01 15.
Article
in English
| MEDLINE
| ID: mdl-34699848
ABSTRACT
More data on the long-term effects of Racemic Ketamine and Esketamine in TDR patients is needed. The implementation of centralized registries of their use for treatment of depression could be a tool of major importance for assessing their efficacy and safety in real-world clinical practice. This paper seeks to outline the rise and rationale behind these registry-based surveillance systems.